Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Research Network

Collaboration Network

45 collaborators·82 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Hôpîtal haut Lévèque

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Yves BECOUARN, Dr

Institut Bergonié Bordeaux

Related
2 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

You Heng LAM, Dr

Centre Paul Papin-ANGERS

Related
1 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

Leila BENGRINE LEFEVRE, Dr

Hôpital Saint Antoine

Related
1 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

Eric FRANCOIS, Dr

Centre Antoine Lacassagne, Nice

Related
4 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

Hervé PERRIER, Dr

Hôpital Saint Joseph

Related
1 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

Emmanuel MAILLARD, Dr

CHR Annecy

Related
1 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

Christophe BORG, Pr

Hôpital Andre Boulloche-MONTBELIARD

Related
1 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

Marie-Pierre GALAIS, Dr

Centre Francois Baclesse-CAEN

Related
1 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

Marie-Claire KAMINSKY, Dr

Centre Alexis Vautrin-VANDOEUVRE LES NANCY

Related
1 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

Bruno BUECHER, Dr

Institut Curie Paris

Related
1 trials

Shared therapeutic areas:

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach

Worked with same sponsors:

UNICANCER
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01443065Phase 2PrincipalInvestigator

MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma

Malignant Neoplasm of EsophagusMalignant Neoplasm of Stomach
Completed

All 1 trials loaded